SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001047469-19-003663
Filing Date
2019-06-17
Accepted
2019-06-17 06:52:50
Documents
16
Effectiveness Date
2019-06-17

Document Format Files

Seq Description Document Type Size
1 DEFM14A a2239048zdefm14a.htm DEFM14A 5011968
2 G554486.JPG g554486.jpg GRAPHIC 13232
3 G166552.JPG g166552.jpg GRAPHIC 4062
4 G794159.JPG g794159.jpg GRAPHIC 32180
5 G427197.JPG g427197.jpg GRAPHIC 20683
6 G166983.JPG g166983.jpg GRAPHIC 57494
7 G315155.JPG g315155.jpg GRAPHIC 53867
8 G360783.JPG g360783.jpg GRAPHIC 75321
9 G556553.JPG g556553.jpg GRAPHIC 67724
10 G325976.JPG g325976.jpg GRAPHIC 81040
11 G296109.JPG g296109.jpg GRAPHIC 79998
12 G875905.JPG g875905.jpg GRAPHIC 61570
13 G748194.JPG g748194.jpg GRAPHIC 16544
14 G103116BGI001.GIF g103116bgi001.gif GRAPHIC 109761
15 G103116BGI002.GIF g103116bgi002.gif GRAPHIC 80445
16 G910142.JPG g910142.jpg GRAPHIC 4015
  Complete submission text file 0001047469-19-003663.txt   6058833
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35952 | Film No.: 19900404
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1